“Real-World Clinical Outcomes of Ujvira® (Trastuzumab Emtansine Biosimilar) in HER2-Positive Breast Cancer: A Retrospective Observational Study in Indian Patients”. Journal of Cancer Research Updates, vol. 14, Aug. 2025, pp. 114-20, https://doi.org/10.30683/1929-2279.2025.14.13.